Esteban Martínez
Infectious Diseases Unit
Hospital Clínic-IDIBAPS
University of Barcelona
Barcelona
Spain
Name/email consistency: high
- Influenza A H1N1 in HIV-infected adults. Martínez, E., Marcos, M.A., Hoyo-Ulloa, I., Antón, A., Sánchez, M., Vilella, A., Larrousse, M., Pérez, I., Moreno, A., Trilla, A., Pumarola, T., Gatell, J.M. HIV Med. (2011)
- Abacavir-based therapy does not affect biological mechanisms associated with cardiovascular dysfunction. Martínez, E., Larrousse, M., Podzamczer, D., Pérez, I., Gutiérrez, F., Loncá, M., Barragán, P., Deulofeu, R., Casamitjana, R., Mallolas, J., Pich, J., Gatell, J.M. AIDS (2010)
- Simplification of antiretroviral therapy with etravirine. Martínez, E., Nelson, M. AIDS. Rev (2010)
- The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters. Martinez, E., Visnegarwala, F., Grund, B., Thomas, A., Gibert, C., Shlay, J., Drummond, F., Pearce, D., Edwards, S., Reiss, P., El-Sadr, W., Carr, A. AIDS (2010)
- Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study. Martínez, E., Larrousse, M., Llibre, J.M., Gutiérrez, F., Saumoy, M., Antela, A., Knobel, H., Murillas, J., Berenguer, J., Pich, J., Pérez, I., Gatell, J.M. AIDS (2010)
- A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression. Martínez, E., Arranz, J.A., Podzamczer, D., Loncá, M., Sanz, J., Barragán, P., Ribera, E., Knobel, H., Roca, V., Gutiérrez, F., Blanco, J.L., Mallolas, J., Llibre, J.M., Clotet, B., Dalmau, D., Segura, F., Arribas, J.R., Cosín, J., Barrufet, P., Casas, E., Ferrer, E., Curran, A., González, A., Pich, J., Cruceta, A., Arnaiz, J.A., Miró, J.M., Gatell, J.M. J. Acquir. Immune Defic. Syndr. (2009)
- Objective amount of limb fat in HIV-infected subjects with subjective diagnosis of lipoatrophy. Martínez, E., Larrousse, M., Podzamczer, D., Gatell, J.M. HIV Med. (2009)
- Cardiovascular disease and HIV infection: host, virus, or drugs?. Martínez, E., Larrousse, M., Gatell, J.M. Curr. Opin. Infect. Dis. (2009)
- Effectiveness of lipid-lowering therapy in HIV patients. Martínez, E., Leyes, P., Ros, E. Curr. Opin. HIV. AIDS (2008)
- Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. Martínez, E., Milinkovic, A., Buira, E., de Lazzari, E., León, A., Larrousse, M., Loncá, M., Laguno, M., Blanco, J.L., Mallolas, J., García, F., Miró, J.M., Gatell, J.M. HIV Med. (2007)
- Retroviruses and opportunistic infections - 13th annual meeting. Martinez, E. IDrugs (2006)
- Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir. Martínez, E., Domingo, P., Galindo, M.J., Milinkovic, A., Arroyo, J.A., Baldovi, F., Larrousse, M., León, A., de Lazzari, E., Gatell, J.M. Clin. Infect. Dis. (2004)
- Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection. Martínez, E., Arnaiz, J.A., Podzamczer, D., Dalmau, D., Ribera, E., Domingo, P., Knobel, H., Riera, M., Pedrol, E., Force, L., Llibre, J.M., Segura, F., Richart, C., Cortés, C., Javaloyas, M., Aranda, M., Cruceta, A., de Lazzari, E., Gatell, J.M. N. Engl. J. Med. (2003)
- The reassurance of experience. Martínez, E. Int. J. STD. AIDS (2003)
- Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors. Martínez, E., Domingo, P., Ribera, E., Milinkovic, A., Arroyo, J.A., Conget, I., Pérez-Cuevas, J.B., Casamitjana, R., de Lazzari, E., Bianchi, L., Montserrat, E., Roca, M., Burgos, R., Arnaiz, J.A., Gatell, J.M. Antivir. Ther. (Lond.) (2003)
